BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 35323851)

  • 1. Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    Magnus MC; Örtqvist AK; Dahlqwist E; Ljung R; Skår F; Oakley L; Macsali F; Pasternak B; Gjessing HK; Håberg SE; Stephansson O
    JAMA; 2022 Apr; 327(15):1469-1477. PubMed ID: 35323851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal outcomes and sinopharm BBIBP-CorV vaccination during pregnancy.
    Hatami D; Habibelahi A; Changizi N; Heidarzadeh M; Nojomi M; Rast M; Ansari K; Tehrani-Banihashemi A
    BMC Pregnancy Childbirth; 2024 Mar; 24(1):190. PubMed ID: 38468216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy and infant outcomes following SARS-CoV-2 infection in pregnancy during delta variant predominance - Surveillance for Emerging Threats to Pregnant People and Infants.
    Reeves EL; Neelam V; Carlson JM; Olsen EO; Fox CJ; Woodworth KR; Nestoridi E; Mobley E; Montero Castro S; Dzimira P; Sokale A; Sizemore L; Hall AJ; Ellington S; Cohn A; Gilboa SM; Tong VT
    Am J Obstet Gynecol MFM; 2024 Feb; 6(2):101265. PubMed ID: 38135220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.
    Karlstad Ø; Hovi P; Husby A; Härkänen T; Selmer RM; Pihlström N; Hansen JV; Nohynek H; Gunnes N; Sundström A; Wohlfahrt J; Nieminen TA; Grünewald M; Gulseth HL; Hviid A; Ljung R
    JAMA Cardiol; 2022 Jun; 7(6):600-612. PubMed ID: 35442390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of COVID-19 vaccination and booster on maternal-fetal outcomes: a retrospective cohort study.
    Piekos SN; Hwang YM; Roper RT; Sorensen T; Price ND; Hood L; Hadlock JJ
    Lancet Digit Health; 2023 Sep; 5(9):e594-e606. PubMed ID: 37537121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis.
    Rahmati M; Yon DK; Lee SW; Butler L; Koyanagi A; Jacob L; Shin JI; Smith L
    Rev Med Virol; 2023 May; 33(3):e2434. PubMed ID: 36896895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    Goldshtein I; Nevo D; Steinberg DM; Rotem RS; Gorfine M; Chodick G; Segal Y
    JAMA; 2021 Aug; 326(8):728-735. PubMed ID: 34251417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
    JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Sher ML; Gruber M; Marom I; Zolotarevsky A; Lavie O; Damti A; Zilberlicht A; Bardicef M; Kedar R
    JAMA Pediatr; 2022 Mar; 176(3):290-295. PubMed ID: 34932066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 and pregnancy outcomes under universal and non-universal testing in Sweden: register-based nationwide cohort study.
    Stephansson O; Pasternak B; Ahlberg M; Hervius Askling H; Aronsson B; Appelqvist E; Jonsson J; Sengpiel V; Söderling J; Norman M; Ludvigsson JF; Neovius M
    BJOG; 2022 Jan; 129(2):282-290. PubMed ID: 34706148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.
    Stock SJ; Moore E; Calvert C; Carruthers J; Denny C; Donaghy J; Hillman S; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Taylor B; Auyeung B; Katikireddi SV; McCowan C; Ritchie LD; Rudan I; Simpson CR; Robertson C; Sheikh A; Wood R
    Lancet Respir Med; 2022 Dec; 10(12):1129-1136. PubMed ID: 36216011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy Outcomes in Patients After Completion of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Compared With Unvaccinated Patients.
    Morgan JA; Biggio JR; Martin JK; Mussarat N; Elmayan A; Chawla HK; Kandalaft S; Magalski GR; Puri P; Williams FB
    Obstet Gynecol; 2023 Mar; 141(3):555-562. PubMed ID: 36735413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductions in stillbirths and preterm birth in COVID-19-vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes.
    Hui L; Marzan MB; Rolnik DL; Potenza S; Pritchard N; Said JM; Palmer KR; Whitehead CL; Sheehan PM; Ford J; Mol BW; Walker SP
    Am J Obstet Gynecol; 2023 May; 228(5):585.e1-585.e16. PubMed ID: 36336084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.
    Dick A; Rosenbloom JI; Gutman-Ido E; Lessans N; Cahen-Peretz A; Chill HH
    BMC Pregnancy Childbirth; 2022 Feb; 22(1):166. PubMed ID: 35227233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study.
    Fell DB; Dimanlig-Cruz S; Regan AK; Håberg SE; Gravel CA; Oakley L; Alton GD; Török E; Dhinsa T; Shah PS; Wilson K; Sprague AE; El-Chaâr D; Walker MC; Barrett J; Okun N; Buchan SA; Kwong JC; Wilson SE; Dunn SI; MacDonald SE; Dougan SD
    BMJ; 2022 Aug; 378():e071416. PubMed ID: 35977737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy.
    Jorgensen SCJ; Drover SSM; Fell DB; Austin PC; D'Souza R; Guttmann A; Buchan SA; Wilson SE; Nasreen S; Schwartz KL; Tadrous M; Wilson K; Kwong JC
    JAMA Pediatr; 2023 Dec; 177(12):1314-1323. PubMed ID: 37870875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil.
    Tavares Veras Florentino P; Cerqueira-Silva T; Freire De Carvalho L; Jôse Oliveira Alves F; De Araújo Oliveira V; Mateus Oliveira Aguilar G; De Sousa Prado R; Soranz D; Pearce N; Boaventura V; Loreiro Werneck G; Oliveira Penna G; Lima Barreto M; Henrique De Oliveira Garcia M; Barral-Netto M; Santos da Paixão E
    Int J Epidemiol; 2023 Dec; 52(6):1708-1715. PubMed ID: 37690066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021.
    Starrfelt J; Danielsen AS; Buanes EA; Juvet LK; Lyngstad TM; Rø GØI; Veneti L; Watle SV; Meijerink H
    BMC Med; 2022 Sep; 20(1):278. PubMed ID: 36050718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
    Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.